Introduction
Vancomycin-resistant Enterococci (VRE) strains were reported first in United Kingdom and France in 1986, and after that in the United States (1) . At present, these organisms are significantly isolated in hospitals around the world, especially in patients with hemato-oncological diseases and hospitalized in intensive care units (2) . Currently, nine types of vancomycin-resistance have been described in Enterococci, eight of these types correspond to acquired resistance, i.e., vanA, vanB, vanD, vanE, vanG, vanL, vanM and vanN; one typeVanC-have been identified in species of Enterococcus gallinarum and E. casseliflavus-E. flavescens intrinsically resistant to low levels of vancomycin but remain susceptible to teicoplanin and have been found in human intestinal tract (3, 4) . Among vancomycin-resistance genotypes in Enterococci, vanA and vanB possess greatest clinical significance (5) . The vanA genotype is the most commonly genotype in VRE worldwide, and is associated with the transfer of a considerable amount of vancomycin resistance from Enterococci, particularly, vancomycin-resistant E. faecium (VREF) to Staphylococcus aureus (1, 6) . The vanA-type genes play an important role in inducing resistance against both teicoplanin and vancomycin, while the level of resistance to vancomycin in strains sheltering vanBtype genes are not constant but somewhat variable (MICs, 4 to 1,024 mg/l). Moreover, remain susceptible to teicoplanin (MICs, ≤ 2 mg/l) in vitro (4) . The low-level resistance against such antibiotics as vancomycin vancomycin (vancomycin [MIC] , 64-128 mg/ml) and susceptibility or intermediate resistance to teicoplanin (teicoplanin MIC, 8-16 mg/ml) is one of the main features of the vanD phenotype (7). Although these organisms lacking strong virulent factors, but enterococcal infection is intricated by the intrinsic resistant / tolerant to many important antimicrobial agents including cephalosporin, lincomycin, cotrimoxazole, and low levels of penicillin and aminoglycosides, and as well as by the ability to acquire resistance to penicillins, chloramphenicol, tetracyclines, aminoglycosides (high-level) and vancomycin either by mutation, or by acquisition of plasmids or transposons (8, 9) . Thus, the incidence of antimicrobial resistant Enterococci, especially VRE is a persisting clinical problem in public health care facilities in all geographical areas (9) . Cytolysin (Cyl), gelatinase (GelE) and aggregation substance (Agg) are virulence factors identified in E. faecalis that can influence the relationship between parasite and host, on other hand, esp and hyl have been found in both E. faecalis and E. faecium (10, 11) . "These virulence factors may causes increasing persistence of enterococci in the nosocomial environment, and consequently inter and intrahospitals dissemination" (10) . Regarding the virulence determinants in clinical isolates of Enterococci that may result in promoting emergence of infections and persistence of this organism in nosocomial settings and consequently leads to increased resistance (5), this study was undertaken to determine the antimicrobial susceptibility patterns and virulence factors including esp (enterococcal surface protein), asa 1 (aggregation substance), gelE (gelatinase), hyl (hyaluronidase) in clinical isolates of E. faecalis and E. faecium.
Materials and Methods

Identification of enterococcal isolates
One hundred and seventy-five E. faecalis and sixtyseven E. faecium isolates were collected from different clinical specimens submitted in three teaching hospitals located in Hamedan/ western Iran, from Dec 2012 to May 2014. The origins of isolates were as follows: urine 200 (82.6%), tracheal 17 (7%), blood 8 (3.3%), wound 6 (2.5%), abscess and lower respiratory tract 6 (2.5%), and body fluids 5 (2.1%). Enterococcus genus were identified using routine microbiological methods (9) then, PCR targeting D-alanine-D-alanine ligases specific for E. faecalis (ddl E. faecalis) and E. faecium (ddl E. faecium) was used to confirm phenotypic speciation (12) .
DNA extraction
Enterococci chromosomal DNA was extracted by boiling method. Briefly, 3-5 clones of overnight bacterial culture was suspended in 500 µl of sterile distilled water, boiled for 10-15 min, and then centrifuging at 14000 g for 5 min to pellet cell debris (13) .
Detection of E. faecalis and E. faecium species by PCR PCR reactions of ddl E.faecalis and ddl E.faecium genes were performed with previously designed primers (Table 1) , with some modification on Kariyama's protocol (12) using Eppendorf and Biorad thermocycler (ASTEC Co., Japan) in a final volume of 20 µl containing 2 µl template DNA, 1 µl of each primer, 10 µl of Master Mix, 6 µl of sterile distilled water. The optimum conditions of PCR for both genes were as follows: an initial denaturation at 95 ºC for 5 min, followed by amplification by 30 cycles of denaturation at 95 ºC for 30 sec, annealing at 52.5 ºC for 30 sec and elongation at 72 ºC for 1 min, and a final extension at 72 ºC for 10 min. The E. faecalis ATCC 29212 and E. faecium BM4147 were used as quality control strains.
Antibiotic susceptibility testing
Antibiotic susceptibility testing of 175 E. faecalis strains and 67 E. faecium strains was performed using Kirby-Bauer disk diffusion method on MullerHinton agar in according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (14) . Antimicrobial agents used in this study were included: vancomycin (30 µg), teicoplanin (30 µg), tetracycline (30 µg), erythromycin (15 µg), norfloxacin (10 µg), ciprofloxacin (5 µg), nitrofurantoin (300 µg), quinopristin-dalfopristin [synercid (15 µg)] (Mast co., UK), chloramphenicol (30 µg), linezolid (30 µg), gentamicin (10 µg), and ampicillin (10 µg) (HiMedia Mumbai Co., India). Determination of minimum inhibitory concentration (MIC) of the glycopeptide antibiotics i.e. vancomycin and teicoplanin (Sigma-Aldrich, Poole, Co., UK) for E. faecalis and E. faecium isolates was done using microdilution broth method and Cation Adjustment Muller Hinton Broth (CAMHB) medium according to the CLSI guidelines (14) . The E. faecalis ATCC 29212 (Vancomycin sensitive), E. faecalis ATCC 51299 (vanB positive), E. faecalis E206 (vanA positive) were used as quality control strains for performing antimicrobial tests. 
Detection of van determinants
Isolates with a vancomycin and teicoplanin Minimum Inhibitory Concentration (MIC) of 2 µg/ml were analyzed by PCR for the presence of the genes encoding the vancomycin-resistance determinants vanA, vanB, vanD using specific primers ( 
Antimicrobial susceptibility testing
Resistance to the majority antibiotics except for chloramphenicol, tetracycline, and quinopristindalfopristin was higher in E. faecium isolates than E. faecalis isolates. However, they showed good rate of sensitivity to linezolid (100%), nitrofurantoin and chloramphenicol (74.6%). All isolates of E. faecalis were susceptible to nitrofurantoin. None of the Enterococcus isolates was resistant to linezolid. The susceptibility patterns of E. faecium and E. faecalis to antibiotics are presented in Table 2 . Of 175 isolates of E. faecalis, resistance of 9 and sensitivity of 166 isolates to vancomycin and teicoplanin were confirmed by microdilution broth method. (Table 3) .
Analysis of vanA-vanB-vanD types vancomycin resistance genes
All VRE fs and 49 of VRE fm strains (96.7%) had high-level resistance to vancomycin and teicoplanin carried the vanA gene. Two VRE fm isolates (3.3%) had moderate-Level resistant to vancomycin with MIC=8 µg /ml and were insensitive to teicoplanin, carried the vanB gene, vanD gene was identified in none of VRE strain.
Prevalence of virulence genes in E. faecalis and E. faecium strains
Among the E. faecalis strains, the asa 1 gene was the most prevalent factor, followed by the esp and hyl genes; additionally, in E. faecium strains, the asa 1 gene was the highest prevalence and hyl gene has the lowest frequency, followed by the esp gene. 
Results of statistical analysis
Using SPSS software, there were significant correlations between the disk diffusion agar and broth microdilution methods for vancomycin and teicoplanin antibiotics (P≤0.001); and between PCR and MIC Vanco and MIC Teico results (P≤0.001) in strains of E. faecalis and E. faecium.
Discussion
In the present study, of 280 enterococcal isolates, 175 isolates were identified as E. faecalis, 67 as E. faecium and 38 as Enterococcus spp. The prevalence of E. faecalis strains were reported 76% and 55.5% respectively (15, 9) . In Iran, the prevalence of E. faecalis and E. faecium strains were reported 77.5% and 22.5%, 70.4% and 18.5%, 85.3% and 10.8%, 28% and 71%, respectively (8, (16) (17) (18) . VRE strains are resistant to different classes of antibiotics simultaneously. Rising high-level resistance to penicillin, ampicillin and aminoglycosides has been demonstrated in recent years, especially in vancomycin-resistant E. faecium strains. Multidrugresistant strains of Enterococci, especially E. faecalis and E. faecium are serious problems in treatment patients with enterococcal infections due to improper use of antibiotics (19) . In the current study, 85% of strains of E. faecalis and all E. faecium strains had multidrug resistance, but strains of vancomycin-resistant compared to susceptible strains were resistant to greater number of antibiotic classes.
In the current study, the prevalence of vancomycin resistance was found 24%, which was consistent with some previous (9, 20) . (38) demonstrated that the strong correlation between the carriage of gene esp and antimicrobial resistance could be due to the higher conjugation frequencies in strains carrying the esp gene than strains lacking this gene. E. faecium strains carrying the gene esp were resistant to more than 90% of the antibiotics tested and 64% of E. faecium strains were resistant to vancomycin (5) . Considering these results, the gene esp facilitates E. faecium isolates ability to acquire antibiotic resistance genes. The expression level of gene esp depending on growth conditions constantly vary between strains of E. faecium and is associated with initial connection and biofilm formation (39) .
Conclusion
Due to increasing resistance rate of Enterococci to most common antibiotics, applying the preventive and control measures are required.
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